Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Real-world Study Comparing the Effectiveness of Ofatumumab and Ocrelizumab Treatment in Multiple Sclerosis Patients

Novartis Pharmaceuticals · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
multiple-sclerosisreal-world-evidence
multiple sclerosis, anti-cd20 monoclonal antibody, ofatumumab, ocrelizumab, real-world evidence, comparative effectiveness, annualized relapse rate, healthcare resource utilization, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 915891
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.